Aptarro (formerly Alpha II), a leading provider of Revenue Cycle Management (RCM) solutions for healthcare networks across the U.S, announces two pivotal leadership appointments as part of its continued focus on innovation and delivering customer-first solutions. Lori Jones joins as Chief Growth Officer, and Dave Douglas has been promoted to Chief Operating Officer. These strategic moves, alongside Aptarro’s recent rebrand, highlight the company’s momentum in helping healthcare organizations break through complexity and drive measurable value.
Lori Jones Appointed as Chief Growth Officer
Lori Jones brings nearly three decades of transformative leadership in healthcare technology and services. She has a proven track record of scaling organizations and driving operational excellence. In her new role, Lori will oversee sales, strategic partnerships, marketing, product, and customer success functions, ensuring cohesive strategies that deliver exceptional value to Aptarro’s clients.
“Lori’s appointment represents another exciting step in Aptarro’s growth journey,” said Ashley Womack, CEO of Aptarro. “Her proven ability to scale organizations and drive customer-focused growth aligns perfectly with our vision for Aptarro. We are confident she will play a critical role in shaping our next chapter of growth and customer success.”
Dave Douglas Promoted to Chief Operating Officer
Dave Douglas, who has been with Aptarro for over 12 years, has been promoted from EVP of RCM Operations to Chief Operating Officer. Dave has been instrumental in advancing Aptarro’s operational strategies, optimizing workflows, and enhancing customer experiences across our solutions. Before joining Aptarro, Dave held leadership roles at GE Healthcare.
“Dave’s extensive expertise in optimizing complex operations and his deep understanding of the healthcare technology space make him the perfect fit to lead our operations as COO,” said Ashley Womack. “His strategic mindset and commitment to excellence will help Aptarro scale effectively as we continue to elevate and deliver value to our customers.”
Aptarro is backed by TA Associates, a leading global private equity firm. “These leadership appointments mark an important step in Aptarro’s evolution as a company dedicated to helping healthcare organizations deliver quality patient care and achieve meaningful results,” said Mark Carter, Managing Director at TA and member of Aptarro’s Board of Directors. “We believe Lori and Dave’s complementary expertise will help drive greater innovation and impact for our clients.”
This announcement follows Aptarro’s recent rebrand, which reflects its bold vision to help customers break through complexity and drive value in the revenue cycle management space.
